These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Colonization with cagA-positive Helicobacter pylori strains inversely associated with reflux esophagitis and Barrett's esophagus. Loffeld RJ; Werdmuller BF; Kuster JG; Pérez-Pérez GI; Blaser MJ; Kuipers EJ Digestion; 2000; 62(2-3):95-9. PubMed ID: 11025356 [TBL] [Abstract][Full Text] [Related]
48. Gastroesophageal Reflux Disease in Time Covering Eradication for All Patients Infected with Helicobacter pylori in Japan. Sugimoto M; Uotani T; Ichikawa H; Andoh A; Furuta T Digestion; 2016; 93(1):24-31. PubMed ID: 26789391 [TBL] [Abstract][Full Text] [Related]
49. Effect of Helicobacter pylori eradication on reflux esophagitis therapy: a multi-center randomized control study. Xue Y; Zhou LY; Lin SR; Hou XH; Li ZS; Chen MH; Yan XE; Meng LM; Zhang J; Lu JJ Chin Med J (Engl); 2015 Apr; 128(8):995-9. PubMed ID: 25881589 [TBL] [Abstract][Full Text] [Related]
50. Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma. Clark GW World J Surg; 2003 Sep; 27(9):994-8. PubMed ID: 14560364 [TBL] [Abstract][Full Text] [Related]
51. Helicobacter pylori, ethnicity, and the gastroesophageal reflux disease spectrum: a study from the East. Rajendra S; Ackroyd R; Robertson IK; Ho JJ; Karim N; Kutty KM Helicobacter; 2007 Apr; 12(2):177-83. PubMed ID: 17309756 [TBL] [Abstract][Full Text] [Related]
52. Lansoprazole: a comprehensive review. Zimmermann AE; Katona BG Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323 [TBL] [Abstract][Full Text] [Related]
53. Acid control and regression of Barrett's esophagus: is the glass half full or half empty? Castell DO; Katz PO Am J Gastroenterol; 1997 Dec; 92(12):2329-30. PubMed ID: 9399786 [No Abstract] [Full Text] [Related]
54. pH, healing rate, and symptom relief in patients with GERD. Huang JQ; Hunt RH Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580 [TBL] [Abstract][Full Text] [Related]
55. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease. McColl KE; Dickson A; El-Nujumi A; El-Omar E; Kelman A Am J Gastroenterol; 2000 Jan; 95(1):101-5. PubMed ID: 10638566 [TBL] [Abstract][Full Text] [Related]
56. The use of proton pump inhibitors in children: a comprehensive review. Gibbons TE; Gold BD Paediatr Drugs; 2003; 5(1):25-40. PubMed ID: 12513104 [TBL] [Abstract][Full Text] [Related]
57. Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer? Okai T; Ohtsubo K; Sakai J; Watanabe H; Motoo Y; Kawashima A; Sawabu N Can J Gastroenterol; 2000 Oct; 14(9):761-6. PubMed ID: 11064311 [TBL] [Abstract][Full Text] [Related]
58. Gastroesophageal reflux disease and the relationship with Helicobacter pylori. Mungan Z; Pınarbaşı Şimşek B Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S61-S67. PubMed ID: 29199171 [TBL] [Abstract][Full Text] [Related]
59. The possible role of Helicobacter pylori in GERD. Falk GW Semin Gastrointest Dis; 2001 Jul; 12(3):186-95. PubMed ID: 11478751 [TBL] [Abstract][Full Text] [Related]